Uh-oh! This study is no longer available.
Early Symptomatic Alzheimer’s Disease
PMG Research of Winston Salem
A research study is evaluating an investigational medication for symptoms of early onset Alzheimer’s Disease.
To be eligible, study participants must:
• Have had a gradual and progressive change in memory function for 6 months or more
• Have a caregiver who will provide information for and about the participant, and will be available for study visits in person or via phone
• Have no significant neurological disease affecting cognitive function other than Alzheimer’s Disease
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 2.5 years
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 26 clinic visits